Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC increased its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 40.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 9,149 shares of the company’s stock after buying an additional 2,635 shares during the period. Sequoia Financial Advisors LLC’s holdings in Bath & Body Works were worth $355,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of BBWI. Fifth Third Wealth Advisors LLC increased its stake in Bath & Body Works by 4.9% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after purchasing an additional 324 shares in the last quarter. SRS Capital Advisors Inc. increased its position in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares in the last quarter. TD Private Client Wealth LLC raised its holdings in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares during the period. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC grew its position in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on BBWI shares. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $42.00 to $48.00 in a report on Friday, January 10th. Robert W. Baird raised their price objective on Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research report on Friday, February 28th. Telsey Advisory Group reiterated an “outperform” rating and issued a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Cowen restated a “buy” rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Morgan Stanley cut their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $45.06.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $29.97 on Wednesday. Bath & Body Works, Inc. has a one year low of $26.21 and a one year high of $52.99. The company’s fifty day moving average price is $36.10 and its two-hundred day moving average price is $33.99. The company has a market capitalization of $6.49 billion, a price-to-earnings ratio of 7.31, a PEG ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s dividend payout ratio is 21.98%.

Bath & Body Works declared that its Board of Directors has approved a stock repurchase program on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.